prof. RNDr. Michal Masařík, Ph.D.
Head of the research group, Michal Masařík Research Group: Cancer Research Lab
Office: bldg. A20/214
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 3631 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 358
2024
-
Investigation of the potential effects of estrogen receptor modulators on immune checkpoint molecules
Nature Scientific Reports, year: 2024, volume: 14, edition: 1, DOI
-
Navigating the redox landscape: reactive oxygen species in regulation of cell cycle
Redox Report, year: 2024, DOI
-
Prostate cancer diagnosed and staged using UV-irradiated urine samples and a paper-based analytical device
Sensors and Actuators B: Chemical, year: 2024, volume: 403, edition: March 2024, DOI
-
Protein cargo in extracellular vesicles as the key mediator in the progression of cancer
Cell Communication and Signaling, year: 2024, volume: 22, edition: 1, DOI
-
RNAs in tumour-derived extracellular vesicles and their significance in the tumour microenvironment
International journal of cancer, year: 2024, DOI
-
Short-term autophagy inhibition by autophinib or SAR405 does not alter the effect of cisplatin on ATP production in prostate cancer cells
Bratislava Medical Journal - Bratislavské lekárske listy, year: 2024, volume: 125, edition: 2, DOI
2023
-
Autophagy modulators influence the content of important signalling molecules in PS-positive extracellular vesicles
Cell Communication and Signaling, year: 2023, volume: 21, edition: 1, DOI
-
Cancer-associated fibroblasts: Mediators of head and neck tumor microenvironment remodeling
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, year: 2023, volume: 1878, edition: 5, DOI
-
ELEMENTS AND PROTEINS IMAGING BY LA-ICP-MS: MEDICAL AND PHARMACEUTICAL RESEARCH
Year: 2023, type:
-
Engine shutdown: migrastatic strategies and prevention of metastases
Trends in Cancer, year: 2023, volume: 9, edition: 4, DOI